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Effect of Beta-Adrenergic Blockade With Timolol on Myocardial Blood
Flow During Exercise After Myocardial Infarction in the Dog
CHARLES A. HERZOG, MD, DOROTHEE P. AEPPLI, PHD, ROBERT J. BACHE, MD , FACC
Minneapolis. Minnesota
The effect of beta-adrenergic blockade with timolol (40
ltg/kg) on myocardial blood flow during rest and graded
tre~dmill exercise was assessed in 12 chronically instru-
mented dogs 10 to 14 days after myocardial infarction
was produced by acute left circumflex coronary artery
occlusion. During exercise at comparable external work
loads, the heart rate-systolic blood pressure product was
significantly decreased after timolol, with concomitant
reductions of myocardial blood flow in normal, border
and central ischemic areas (p < 0.001) and increases in
subendocardiaJ/subepicardial blood flow ratios (p < 0.05).
In addition to the blunted chronotropic response to ex-
ercise, timolol exerted an effect on myocardial blood flow
In patients with acute myocardial infarction, beta-ad-
renergic blockade has been shown to exert a beneficial effect
both on survival and risk of repeat infarction (1-3). The
mechanism underlying this protective effect is uncertain,
but may be related in part to effects of beta-adrenergic
blockade on myocardial oxygen consumption or coronary
blood flow. Previous studies of the effect of beta-adrenergic
blockade on regional myocardial blood flow after coronary
occlusion performed in anesthetized animals (4-10) or in
conscious, resting, acutely ischemic animals (11-13) have
yielded inconsistent results. Thus, some investigators have
found that beta-adrenergic blockade resulted in a transmural
redistribution of blood flow within the ischemic area with
increased flow to the subendocardium when heart rate after
beta-adrenergicblockade was not different from control (8,12) ,
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that was not explained by changes in heart rate or blood
pressure. At comparable rate-pressure products during
exercise, total myocardial blood flow was 24% lower
after timolol (p < 0.02) and flow was redistributed from
subepicardium to subendocardium in all myocardial
regions.
Thus, timolol altered myocardial blood flow during
exercise by two separate mechanisms: 1) a negative
chronotropic effect, and 2) a significant selective reduc-
tion of subepicardial perfusion independent of changes
in heart rate or blood pressure with transmural redis-
tribution of flow toward the subendocardium.
while others have found no effect of beta-adrenergic block-
ade on the transmural distribution of perfusion (6, 10, 11).
No experimental data exist that examine the effect of beta-
adrenergic blockade on regional myocardial perfusion dur-
ing exercise after myocardial infarction .
We have analyzed the effect of timolol on regional myo-
cardial blood flow in dogs during graded treadmill exercise
10 to 14 days after myocardial infarction, a model chosen
to simulate the clinical use of beta-adrenergic blocking pro-
phylaxis in patients after myocardial infarction. We were
particularly interested . in determining whether beta-adre-
nergic blockade would have an effect on the transmural
distribution of myocardial blood flow independent of changes
in heart rate.
Methods
Surgical preparation. Twenty-one adult mongrel dogs
of both sexes weighing 20 to 32 kg and trained to run on
a motor driven treadmill were anesthetized with intravenous
sodium pentobarbital (20 to 25 mg/kg) and ventilated with
a respirator. A left thoracotomy was performed in the fourth
intercostal space and the heart was suspended in a pericardial
cradle. A heparin filled PVC catheter (3.5 mm outer di-
ameter) was inserted into the aortic root through the left
internal thoracic artery. Similar catheters were inserted into
the left ventricular cavity through a stab wound in the apical
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dimple and into the left atrium through the atrial appendage.
The left circumflex coronary artery was dissected free and
two snare type occluders (14) were positioned around the
artery, one proximal and the other distal to the first left
ventricular branch. The catheters and occluders were tun-
neled to a subcutaneous pouch at the base of the neck.
Production of infarction. Seven to 10 days after sur-
gery the dogs were returned to the laboratory for production
of myocardial infarction. The snares were exteriorized from
the subcutaneous pouch with 2% lidocaine infiltration anes-
thesia. Lead II of a standard electrocardiogram was moni-
tored continuously. Morphine sulfate (5 mg) was admin-
istered intravenously before coronary occlusion and additional
doses were given as needed to maintain the animal in a
quiet resting state. Lidocaine was administered as necessary
to control ventricular arrhythmias in the first 3 hours. The
distal snare was tightened first. If marked ST segment el-
evation was seen on the standard limb leads of the electro-
cardiogram, the proximal snare was not tightened. If no ST
segment elevation occurred, the proximal snare was tight-
ened 15 minutes after distal occlusion. Prompt marked ST
segment elevation or depression occurred in every case.
Three dogs died in intractable ventricular fibrillation within
1 hour of coronary occlusion. One dog was found dead 4
days after infarction. Two dogs developed sepsis after sur-
gery and were excluded from further study. One dog chewed
off its aortic catheter and exsanguinated. Studies of regional
myocardial blood flow were performed in 14 surviving dogs.
After coronary occlusion, the dogs were exercised for ap-
proximately 10 minutes twice weekly to maintain familiarity
with the treadmill.
Study protocol. Measurements of regional myocardial
blood flow were performed 10 to 14 days after coronary
occlusion. On the morning of study, the catheters were
exteriorized from the subcutaneous pouch with 2% lidocaine
infiltration anesthesia. The catheters were attached to Sta-
tham P37Db pressure transducers fastened at midchest level
to a nylon vest (Alice King Chatham). A polyethylene tube
also connected the arterial catheter to a Harvard Apparatus
model 1210 constant rate withdrawal pump to obtain ref-
erence arterial blood samples. Phasic and mean arterial pres-
sures. phasic left ventricular and mean left atrial pressures
were recorded continuously on a Hewlett Packard model
8800 direct writing oscillograph.
Determinations ofmyocardial bloodfiow were performed
by serial injections of 15 micron microspheres labeled with
gamma emitting radionuclides C25I, 57CO, 51Cr, 113Sn, 85Sr,
95Nb and 46SC). Before injection, microspheres were mixed
for 15 minutes in an ultrasonic bath. During each interven-
tion 3 x 106 microspheres were injected into the left atrium
over a 15 second interval and the atrial catheter was flushed
with 10 ml of isotonic saline solution. Beginning 5 seconds
before each injection and continuing for 90 seconds after
injection, a reference sample of arterial blood was with-
drawn at a constant rate. Microsphere injections resulted in
no detectable hemodynamic change.
Before study, a period of warm up exercise was used to
establish the response of heart rate to increasing levels of
graded treadmill exercise. Two exercise levels were chosen
to produceheart rates of approximately 190and 220 beats/min.
Because timolol reduced exercise-induced tachycardia by
about 20%, a third, more strenuous exercise level was em-
ployed after timolol to permit analysis of myocardial flow
before and after beta-adrenergic blockade at comparable
heart rates. Myocardial blood flow was measured during
control conditions at rest and during two exercise levels (E1
= 6.0 ± 0.7 km/h, 4% grade; E2 = 9.8 ± 0.7 km/h, 4%
grade; all data expressed as mean ± standard error of the
mean). Microspheres were injected 2 minutes after a steady
level of heart rate and blood pressure were achieved and
exercise was continued for 1.5 minutes after microsphere
injection. After a 90 minute rest period, intravenous timolol
(40 JLg/kg) was given, a dose that produces at least an
80% blockade of isoproterenol-induced increases in heart
rate (15). The drug has a half-life of 2 hours in dogs (16).
Repeat measurements were begun 15 minutes after drug
administration during rest and then during graded treadmill
exercise (El, E2 identical to control and E3 = 12.3 ± 0.7
km/h, 4% grade). Three dogs became too fatigued to attain
the E3 level after timolol and therefore were restudied at
that exercise level on the next day.
Determination of infarct size and radioactivity. The
dogs were sacrificed after study with a lethal dose of sodium
pentobarbital and the hearts were removed and weighed.
The lumen of the circumflex coronary artery was examined
to verify total occlusion. The great vessels, atria and right
ventricle were dissected from the left ventricle. The left
ventricle was sectioned into four transverse rings of equal
thickness from base to apex, stained with triphenyltetra-
zolium chloride to identify the area of infarction and fixed
in 10% buffered formalin (17). Both sides of the fixed rings
and infarct border were traced on sheets of clear plastic and
the infarct area was estimated by computerized planimetry.
The mean infarct area for each ring was multiplied by the
weight of that ring to obtain infarct weight. Total infarct
weight was obtained as the sum of infarct weight for the
four rings.
The two central rings were divided into six circumfer-
ential regions corresponding to the anterior left ventricular
wall, interventricular septum, posterior wall, posterior pap-
illary muscle region, lateral wall and anterior papillary mus-
cle region (14). Each specimen was then divided into four
transmural layers of equal thickness from epicardium to
endocardium and weighed. Specimens were placed in count-
ing vials; myocardial and reference blood samples were
counted in a gamma spectrometer with a multichannel ana-
lyzer (model 5912, Packard Instrument Co.) at window
settings selected to correspond to peak emission energies of
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each radionuclide. Recorded activity in each energy window
was corrected for background activity and overlapping counts
from the accompanying isotopes (18).
Myocardial blood flow (mllmin) was computed with the
formula: Fm = (F, X Cm)/C" where Fm = myocardial
sample blood flow (mllmin), F, = reference blood flow
(ml/min), Cm = counts per minute of the myocardial sam-
ples and C, = counts per minute of reference flow samples.
Sample blood flows were expressed as mllmin per gram of
myocardium.
Statistical methods. Hemodynamic measurements were
taken from the strip charts. Values obtained during control
conditions and after timolol were compared using Student's
t test for paired data; the resultant probability (p) values
were adjusted using the Bonferroni inequality to correct for
multiple tests on correlated data (19).
Infarcts involved the posterior papillary muscle speci-
mens. Accordingly, flows were analyzed in the "infarct
zone" (posterior papillary muscle region), "border areas"
(lateral and posterior regions) and "nonischemic areas."
Initially, flows were compared in the nonischemic septum,
anterior and anterior papillary muscle regions. Because no
significant differences were found among these three re-
gions, flows for the "normal" area were calculated as the
mean of these three regions. Blood flow in the posterior and
lateral regions was analyzed with respect to flow averaged
over transmural layers and adjacent regions. Changes in
distribution of transmural blood flow (epicardium to en-
docardium), regional "horizontal" flow (that is, nonin-
farcted region to infarct), and differences in "vertical" flow
(that is, base to apex) were examined. Changes in flows
were evaluated by multivariate analyses of covariance
(MANOVA) (20). Subsequently, univariate analyses of
covariance were performed on the factors affecting changes
in flow which were found to be statistically significant with
the MANOVA (20).
Table 1. Hemodynamic Data
Endocardial! epicardial flow ratios and mean myocardial
blood flow for control and after timolol were compared by
two stage paired t tests, the first stage assessing each trans-
mural layer of the region for the difference between control
and timolol simultaneously for the three exercise levels
(MANOVA) and the second evaluating the difference for
each exercise level within a region Both stages were sub-
jected to Bonferroni's adjustment for multiple comparisons
(19).
Results
Infarct location. Myocardial blood !flow was studied in
14 dogs. One experiment was unsuccessful because of fail-
ure of the arterial blood reference pump, Another study was
unsuitable for data analysis because of an error in myocardial
sectioning. Twelve remaining complete studies were used
for data analysis, Mean left ventricular weight was 125 ±
37 g. An infarct was seen in all dogs studied. It was pre-
dominantly subendocardial and always involved the pos-
terior papillary muscle, In the posterior papillary muscle
region, small areas of noninfarcted tissue were present in
the edges of some specimens; thus even the subendocardial
layer was not totally infarcted in all specimens. The arbitrary
designation of the lateral and posterior regions as "border
zones" is for semantic purposes because these regions con-
tained myocardium adjacent to the infarcted area. In some
instances, small areas of infarcted tissue were present in the
medial edge of the lateral and posterior region subendocar-
dial specimens. Most of the infarct was located in rings two
and three, and mean infarct weight represented 5 7+ 3 9%
(range 1.1 to 125) of the total left ventricle
Hemodynamic data (Table 1). Compared with control,
timolol significantly reduced heart rate at rest and during
exercise, so that heart rates were comparable at exercise I
_..-----
Heart Rate x Systolic
Heart Rate Systolic Aortic Diastolic Aortic LVEDP Aortic Pressure
Exercise Level (beats/min) Pressure (mm Hg) Pressure (mm Hg) (mIT' Hg) (beats x mm Hg/min)
---_._--,
Rest
Control 104 ± 5 116 ± 4 77 ± 2 8 ± 2 12.nO ± 760
Timolol 97 ± 5* 116 ± 5 82 ± 4* \) -;:- 2 11.220 :t 67 (}
EI
Control 190 ± 4 147 ± 7 86 ± 4 16 ± 1 27,840 ± I 510
Timolol 156 ± 4t 144 ± 7 102 ± 6t 18 ± 2 22,550 -:>- IARO"
E2
Control 220 ± 4 160 ± 8 85 ± 3 20 :!: 4 35,220 ± !9(iO
Timolol 178 ± 3t 157 ± 10 100 ± 6 22 ± 3 27,900 -+: 2.140*
E3
Timolol 193 ± 3 162 ± 9 96 ± 7 24 + 3 ,P.210 c.!: 1,1)50
---_.-----_..~ - ---------.
*p < 0.05 timolol versus control; tp < 0.001 timolol versus control. Values are reported ;IS mean ± standard error of the mean. El = exercise
level one (6.0 ± 0.7 km/h, 4% grade); E2 = exercise level two (9.8 ± 0.7 krn/h, 4% grade); E3 = exercise level three (12.3 ± 0.7 km/h. 4% grade);
LVEDP = left ventricular end-diastolic pressure.
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(EI) control and exercise 3 (E3) timolollevels. Timolol did
not affect systolic pressure or the increase in systolic pres-
sure with exercise, but diastolic blood pressures after timolol
were higher at rest (p < 0.05) and during EI level (p <
0.001). Left ventricular end-diastolic pressure increased
progressively with exercise and was insignificantly in-
creased after timolol. The rate-pressure product (heart rate
x systolic blood pressure) increased steadily with exercise
and was significantly decreased at both the El and E2 levels
after nrnolol (p < 0.05). The mean rate-pressure product
at E3 timolol level was 8.5% lower than E2 control, but
this was not statistically significant.
Effect of timolol on myocardial blood flow. Mean
myocardial blood flow and the endocardial/epicardial flow
ratios are summarized in Table 2. Because analysis of var-
iance testing demonstrated no statistically significant dif-
ference in flows between the rings, mean flow data for rings
two and three are shown. During control conditions, ex-
ercise resulted in a progressive transmural redistribution of
flow away from the subendocardium which was most pro-
nounced in the posterior papillary muscle region. During
resting conditions, neither mean myocardial blood flow nor
the endocardial/epicardial flow ratio was significantly dif-
ferent after timolol. At both the EI and E2 levels, timolol
significantly reduced blood flow to all regions (p < 0.001)
during exercise, while endocardial/epicardial flow ratios were
significantly increased after timolol in all regions (p < 0.05).
Figures I and 2 display the relation between blood flow
and rate-pressure product during control conditions and
after timolol in the subendocardium (layer four) and sub-
epicardium (layer one), respectively. Beta-adrenergic block-
ade (Fig. I) did not significantly alter subendocardial flow
in the posterior papillary muscle and posterior regions at
comparable rate-pressure products, but did cause a small
decrease in subendocardial flow in the normal and lateral
regions. The relation between flow and rate-pressure product
(Fig.2) appeared to be linear in the normal, posterior and
lateral subepicardium during control conditions. Timolol
caused a reduction in subepicardial flow in all regions at
comparable rate-pressure products during exercise. Figure
3 compares regional endocardial/epicardial flow ratios and
rate-pressure products during control conditions and after
timolol. There was redistribution of flow toward the sub-
endocardium after timolol in all regions, although the dif-
ference in the posterior papillary muscle region was trivial.
Similar graphic relations (not shown) were obtained when
blood flow was plotted with respect to heart rate rather than
rate-pressure product.
Factors atTeC~ing transmural blood flow. Table 3 shows
the analysis of variance for variables affecting transmural
flow. The contributions of treatment (timolol), individual
variation among (jogs, heart rate and diastolic pressure to
changes in transmural flow were examined. Systolic blood
pressure (not shown) was not an independent contributor to
Table 2. Mean Regional Myocardial Blood Flow and Endocardial/Epicardial Flow Ratios
Exercise
Flow (ml/min per g) Endo/Epi Ratios
Level Control Timolol Control Timolol
Rest
Normal 1.33 ± 0.12 1.29 ± 0.11 1.35 ± 0.06 1,41 ± 0.06
Posterior 1.01 ± 0.10 1.04 ± 0.12 1.02 ± 0.10 1.16 :t 0.11
Lateral 0.97 ± 0.11 0.98 ± 0.10 1.15±0.14 1.26 ± 0.13
PPM 0.82 ± 0.10 0.85 ± 0.12 0.51 ± 0.08 0.58 :t 0.06
El
Normal 2.78 ± 0.16 2.02 ± 0.24t 1.21 ± 0.04 1,40 ± 0.06*
Posterior 2.11 ± 0.16 1.48 ± 0.16t 0.80 ± 0.09 1.01 :t 0.13*
Lateral 1.97 ± 0.21 1.44 ± 0.20t 0.87 ± 0.10 1.15 ± 0.15*
PP\f 1,43 ± 0.17 1.06 ± 0.15t 0.20 ± 0.05 0.29 ± 0.06*
E2
Normal 3,42 ± 0.29 2.14 ± 0.16t 1.19 ± 0.08 1.35 ± 0.06*
Posterior 2,48 ± 0.20 1.59 ± 0.15t 0.70 ± 0.09 0.92 ± 0.11*
Lateral 2.29 ± 0.23 1,47 ± 0.15t 0.83 ± 0.12 1.00 ± 0.12*
PPM 1.51 ± 0.16 1.08 ± 0.14t 0.20 ± 0.05 0.29 ± 0.06*
E3
Normal 2.52 ± 0.29+ 1.32 ± 0.06+
Posterior 2.05 ± 0.27t 1.07 ± 0.13+
Lateral 1.66 ± 0.21t 0.91 ± 0.13
PPM 1.33 ± 0.19 0.28 ± o.ou
(p = 0.07)
'r < 0.05 timolol versus control; tp < 0.001 timolol versus control; :j:p < 0.05 E3 timolol versus E2 control. Values are reported as mean ±
standard error of the mean. ENDO/EPI = endocardial/epicardial; PPM = posterior papillary muscle region.
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Subendocardial Blood Flow
Figure 1. Relation between regional sub-
endocardial blood flow and rate-pressure
product at rest and during treadmill ex-
ercise , during control conditions and after
intravenous administration of timolol , 40
JLg/kg.
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changes in flow. In the normal region , the effects of heart
rate and individual variation among dogs were highly sig-
nificant (p = 0.(01 ). In addition , timolol had a statistically
significant (p = 0.018) primary effect on transmural flow,
which was not explained by changes in heart rate or diastolic
blood pressure. The lateral 'region behaved similarly to the
normal region . In the infarct region (posterior papillary mus-
cle region), the effects of heart rate and individual variation
among dogs were highly significant (p < 0.(01), while the
effect of diastolic blood pressure was of borderline signif-
icance (p = 0.050) . Timolol had a significant primary effect
on transmural flow (p = 0.024) distinct from its hemody-
namic effects . The posterior region was similar to the pos-
terior papillary muscle region.
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Transmural distribution of blood flow after timolol.
Figure 4 is a three-dimensional representation of the effect
of timolol on transmural myocardial blood flow in the pos-
terior papillary muscle , posterior and septal region s. The x
axis represents the region , the y axis is flow and the z axis
represents the transmural layer . Because the mean heart rate
for all flow studies (control and timolol) was 161 beats/min ,
we have analyzed transmural flow at this heart rate . With
timolol , transmural redistribution of flow occurred with little
or no change in flow to layer four (subendocardium) and a
significant decrease in flow to layer one (subepicardium).
If the timolol-induced changes in flow are viewed in terms
of endocardial to epicardi al flow gradients, it is apparent
that each region behaved somewhat differently. Timolol
Subepicardial Blood Flow
0.8
Figure 2, Relation between regional sub-
epicardial blood flow and rate-pressure
product at rest and during treadmill ex-
ercise, during control conditions and after
intravenous administration of timolol, 40
JLg/kg. C
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Figure 3. Relation between regional en-
docardial/epicardial (ENDO/EPI) flow ra-
tio and rate-pressure product at rest and
during treadmill exercise, during control
conditions and after intravenous admin-
istration of timolol , 40 J-Lg/kg.
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reduced myocardial blood flow to layer one (and a less extent
to layer two) of the posterior papillary muscle region , layers
one , two and three of the posterior region and all layers of
the nonischemic septal region . Thus , although the major
primary effect of the drug was to reduce subepicardial flow,
this effect was not restricted to the subepicardial layer. Al-
though not apparent in Figure 4, statistical analysis showed
no significant timolol-induced change in the horizontal gra-
dients (that is, from region to region). The same analysis
for the lateral region produced results similar to those for
the posterior region.
From the analysis of variance, we determined the quan-
titative primary effect of timolol on the transmural distri-
bution of blood flow independent of its effect on heart rate
and blood pressure . For each region , the percent change in
the quotient ([subendocardial flow subepicardial
flow)/mean transmural flow of the region) during control
conditions and after timolol expresses the net redistribution
of transmu ral flow as a percent of total regional flow. Ti-
molol caused a 7% redistribution of total flow from sub-
epicardium to subendocardium in the normal region (p <
0.001 versus control ), a 12% redistribut ion of total flow
from subepicardium to subendocardium in the posterior re-
gion (p < 0.001 ) and an 8% redistribution of total flow
from subepicardium to subendocardium in the lateral region
(p < 0 .01). A 7% redistribution of total flow from subepi-
cardium to subendocardium was seen in the posterior pap-
illary muscle region , but this was not significantly different
from control (p = 0.12). We were interested in the effect
of timolol on total left ventricular blood flow. Figure 5
shows the relation between mean blood flow (measured in
rings two and three) and rate-pressure product during control
conditions and after timolol. The plotted regression lines
(calculated from the individual dogs) show a significant
decrease (p < 0.02) in total left ventricular blood flow
during exercise after timolol at comparable rate-pressure
products.
Discussion
Myocardial blood flow and beta-adrenergic blockade.
This study demonstrated two separate effect s of timolol on
myocard ial blood flow during exercise . First, at comparable
external work loads, timolol caused a decrease in total blood
flow to all myocardial regions in proportion to the decrease
in heart rate after beta-adrenergic blockade . Second , timolol
Table 3. Analysis of Variance Testing the Statistical Significance of Independent Variables on Transmural Flow
Region
Normal Lateral PPM Posterior
Source F Sig of F F Sig of F F Sig of F F Sig of F
Main effects 11.88 p < 0.00 1 15.65 P < 0.001 23.20 P < 0.001 25.09 p < 0.001
Dog 13.61 P < 0.00 1 11.37 P < 0.001 14.20 P < 0.00 1 17.66 P < 0.00 1
Heart rate 15.60 p < 0.00 1 63.81 P < 0.001 \23.76 P < 0.00 \ 103.34 P < 0.00\
Diastolic blood pressure 1.00 p = 0.32 1 0.03 P = 0.863 4.05 P = 0 .050 8.44 P < 0.005
Timolol 6.03 p = 0.0 18 6.70 P = 0.0 13 5.42 p = 0.024 5.70 P = 0.021
---
PPM = posterior papillary muscle region; Sig of F = significance of F.
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2.0Figure 4. The effect of timolol on regional trans-
mural myocardial blood flow at a mean heart rate
of 161 beats/min. EPI = subepicardium (layer I);
ENDO = subendocardium (layer 4); l , 2, 3 and
4 = transmural layers I, 2, 3 and 4; POST PAP
0= posterior papillary muscle region; POST =
posterior region; SEPT = interventricular septal
region.
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Figure 5. The effect of timolol on the relation between mean left
ventricular blood flow and rate-pressure product. C = control; T
= timolol. Control flow is indicated by circles and flow after
timolol is indicated by triangles.
caused a transmural redistribution of blood flow with se-
lective reduction of subepicardial flow, which was not ex-
plained by changes in heart rate or blood pressure.
Coronary blood flow is normally closely coupled to myo-
cardial oxygen consumption. Reduction in heart rate by
beta-adrenergic blockade would be expected to exert a major
effect on lessening myocardial oxygen requirements during
exercise. The contribution of increases in myocardial con-
tractility to the increased myocardial oxygen consumption
during exercise is more difficult to assess (21). The heart
rate-systolic blood pressure product does not account for
changes in contractility or ventricular volume; however,
beta-adrenergic blockade produces directionally opposite in-
fluences on myocardial oxygen consumption during exercise
by simultaneously causing reduced contractility and in-
creased wall stress secondary to ventricular enlargement.
These opposing effects may tend to cancel each other when
the rate-pressure product is used to estimate myocardial
oxygen consumption during exercise (22). It is of interest
that at a comparable rate-pressure product, total myo-
cardial blood flow was significantly lower after timolol (24%
lower comparing E2 timolol with El control). Jorgensen et
al. (23) found that at similar rate-pressure products and
similar levels of myocardial oxygen consumption, propran-
olol caused a significant widening of the coronary arterio-
venous oxygen difference and a decrease in myocardial blood
flow in normal human subjects during upright bicycle ex-
ercise. This suggested that propranolol may cause a change
in coupling between myocardial oxygen consumption and
coronary blood flow. Ideally, we would have liked to mea-
sure myocardial oxygen consumption in our animal prep-
aration. However, it is not possible to measure myocardial
oxygen consumption accurately from coronary arteriove-
nous oxygen difference in the setting of heterogeneous per-
fusion because the myocardial area of interest is poorly
perfused or not perfused at all. Coronary sinus effluent,
therefore, disproportionately reflects the contribution of
nonischemic myocardium and underrepresents areas of isch-
emic myocardium (24).
In the present study, administration of timolol caused a
significant increase in diastolic aortic pressure at rest and
during light exercise. This is in agreement with previous
findings (25) that acute beta-adrenergic blockade increases
diastolic blood pressure in unanesthetized dogs at rest and
during exercise and appears to result from the increase in
peripheral vascular resistance produced by acute beta-ad-
renergic blockade.
Comparison with previous studies. Previous studies of
the effect of beta-adrenergic blockade on transmural myo-
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cardial blood flow after coronary artery occlusion have been
conducted with both nonselective and beta-selective block-
ing agents. The contribution of heart rate to changes in flow
has been considered in some of these investigations. Grong
et al. (9) found increased endocardial/epicardial flow ratios
in the infarct border after beta-adrenergic blockade with
timolol in open chest anesthetized cats with acute left an-
terior descending coronary artery occlusions, but heart rate
was not controlled. Berdeaux et al. (6) compared the effects
of beta . selective and nonselective beta-adrenergic blockade
on regional myocardial blood flow after acute left anterior
descending coronary artery occlusion in anesthetized open
chest dogs. Nonselective beta-adrenergic blockade with dl-
propranolol and dl-pindolol induced redistribution of blood
flow from epicardium to endocardium in both ischemic and
nonischemic areas, while beta-blockade with dl-practolol
or atenolol (5) did not produce this effect. This redistribution
of blood flow was abolished by atrial pacing to control heart
rate. Varneret al. (13) examined the effect of acute coronary
occlusion and propranolol administration in resting awake
dogs. In severely ischemic segments, regional wall motion
abnormalities were improved by propranolol. Regional
myocardial blood flow decreased in the normal zone and
increased slightly in the ischemic zone. A small increase in
endocardial/epicardial flow ratio was seen in the moderately
ischemic zone, but not in the normal or severely ischemic
zones. These data suggest that the response of myocardial
blood How may differ, depending on whether beta-adre-
nergic hlockade is performed with a nonselective or selective
beta-adrenergic blocking agent.
In the present study, we found that for exercise which
produced comparable hemodynamic conditions, timolol se-
lectively reduced subepicardial flow with preservation of
subendocardial flow, suggesting that subepicardial vascular
resistance was selectively increased. Evidence supporting
the presence of betaj-adrenergic receptors in the coronary
vasculature has been presented by several investigators.
McRaven et al. (26) found that coronary vasodilation produced
by isoproterenol after practolol administration resulted from
stimulation of coronary beta--receptors. Domenech and
MacLellan (27), using anesthetized open chest dogs, found
that beta, activation with salbutamol produced a greater
increase in flow in the subepicardium than the subendocar-
dium. Similarly, Melby and Bache (28), using awake dogs
with acute coronary artery occlusions, found that beta, stim-
ulation preferentially increased flow to the subepicardium
of nonischemic myocardial areas. Thus, although the major
effect of timolol on myocardial blood flow in the present
study resulted from blockade of beta-mediated increases in
myocardial oxygen consumption during exercise, hlockade
of beta-mediated coronary vasodilation may have contrib-
uted to the observed transmural redistribution of perfusion.
Alpha-adrenergic influences. It is also possible that un-
masking alpha-adrenergic vasoconstrictor tone by beta-ad-
renergic blockade could have had a role in decreasing sub-
epicardial flow. Johannsen et al. (29) found that in anesthetized
dogs with intact coronary vasomotor tone, sympathetic nerve
stimulation after propranolol decreased both endocardial and
epicardial flow without transmural redistribution. However,
in open chest dogs given propranolol and doses of adenosine
to produce maximal coronary vasodilation, sympathetic nerve
stimulation significantly decreased subepicardial but not
subendocardial flow; this finding is ascribed either to non-
uniform sympathetic innervation of the coronary vessels or
to nonuniform prejunctional inhibitory effects of adenosine
on adrenergic neurotransmission (29,30).
In our study, timolol did not alter either total myocardial
blood flow or the distribution of perfusion during resting
conditions when sympathetic activity would be expected to
be low and coronary vasomotor tone high. However, during
exercise when coronary vasodilation occurred in response
to increasing myocardial metabolic needs, and when in-
creased sympathetic nervous system activity would be ex-
pected, timolol produced a significant selective decrease in
subepicardial perfusion.
Limitations of this study. In the present study, the pos-
terior papillary muscle region occupied the center of the
area normally perfused by the occluded left circumflex coro-
nary artery and, therefore, represented a myocardial area
dependent on collateral vasculature for its blood supply.
Unlike this central area of collateral-dependent tissue, the
posterior and lateral specimens did not represent a pure
sample of either normally perfused or collateral-dependent
tissue. Instead, these regions represented border areas con-
taining the collateral boundary, which consists of variably
interspersed peninsulas of normally perfused and collateral-
dependent tissue (31). Because of the difficulty in defining
the precise boundary between normal and collateral-depen-
dent myocardium in the presence of substantial collateral
vessel development in these dogs 10 to 14 days after coro-
nary occlusion, it was not possible to determine the precise
admixture of normal and collateral-dependent tissue within
the posterior and lateral specimens. However, using a sim-
ilar experimental model (32), we previously demonstrated
that after coronary occlusion, resting blood flow to an area
containing collateral-dependent myocardium is directly re-
lated to the amount of noninfarcted myocardium within a
specimen. Because blood flow within these border regions
represents the sum of flow to collateral-dependent and nor-
mally perfused areas, the response of blood flow during
exercise would be expected to lie between the normal and
posterior papillary muscle regions, unless abnormal wall
stresses or other abnormalities resulted in unexpected al-
terations in blood flow during exercise. In fact, blood flow
measurements in these border areas lay between the normal
and collateral-dependent regions as predicted. Nevertheless,
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it is clear that blood flow measurements to these border
regions represent the sum of heterogeneous responses of
collateral-dependent and normally perfused tissue.
Clinical implications. The potential therapeutic signif-
icance of timolol-induced changes in the volume and trans-
mural distribution of myocardial blood flow during exercise
is of considerable interest. At comparable rate-pressure
products, timolol resulted in significant reductions of blood
flow in the subepicardium. This effect was distinct from the
hemodynamic effects on heart rate or arterial pressure. Be-
cause total arterial inflow to collateral-dependent areas may
be limited by the resistance offered by the collateral chan-
nels, a reduction in subepicardial flow might be expected
to make more blood available for perfusion of the suben-
docardium. This was not observed in the present study;
subendocardial flow was unchanged after timolol so that
total inflow was decreased at comparable heart rate-systolic
blood pressure products. Nevertheless, if the reduction in
subepicardial blood flow at comparable rate-pressure prod-
ucts resulted from decreased myocardial oxygen demands
produced by timolol, maintenance of constant subendocar-
dial flow in the presence of decreased myocardial oxygen
needs would represent a beneficial effect of timolol. Un-
fortunately, the inability to assess regional myocardial ox-
ygen requirements prevents testing of this hypothesis.
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